| 发明名称 |
HCV IMMUNOTHERAPY |
| 摘要 |
The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load. |
| 申请公布号 |
US2014377218(A1) |
申请公布日期 |
2014.12.25 |
| 申请号 |
US201214236079 |
申请日期 |
2012.08.02 |
| 申请人 |
Morre Michel;Assouline Brigitte;Croughs Therese;Demol Pierre;Beq Stephanie |
发明人 |
Morre Michel;Assouline Brigitte;Croughs Therese;Demol Pierre;Beq Stephanie |
| 分类号 |
A61K38/20;A61K38/21;A61K45/06 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Boulogne FR |
